STOCK TITAN

DaVita (NYSE: DVA) CFO receives new performance-based stock awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACKERMAN JOEL reported acquisition or exercise transactions in this Form 4 filing.

DaVita Inc. insider filing shows equity awards to its CFO. Joel Ackerman, CFO and Treasurer of DaVita Inc., received two grants of common stock, covering 6,585 and 65,997 shares at no cost, as part of performance stock unit awards. These shares relate to performance stock units granted on March 15, 2022 and March 15, 2023, of which 100% will vest on March 15, 2026. Following these awards, he directly holds 221,019 shares of DaVita common stock.

Positive

  • None.

Negative

  • None.

Insights

DaVita’s CFO received routine performance-based stock awards, not market purchases or sales.

The transactions show Joel Ackerman acquiring DaVita common stock through two compensation-related grants, coded as “A” for awards. He received 6,585 and 65,997 shares at a price of $0.00 per share, indicating non-cash equity compensation rather than open-market buying.

Footnotes state the shares were issued upon satisfaction of criteria for performance stock units granted in March 2022 and March 2023, with 100% vesting scheduled for March 15, 2026. After these awards, he directly holds 221,019 shares, suggesting a substantial retained equity stake aligned with long-term performance.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ACKERMAN JOEL

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO and Treasurer
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 A 6,585(1) A $0 155,022 D
Common Stock 03/10/2026 A 65,997(2) A $0 221,019 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares received upon the satisfaction of criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2022, of which 100% will vest on March 15, 2026.
2. Shares received upon the satisfaction of criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2023, of which 100% will vest on March 15, 2026.
Remarks:
/s/ Stephanie Berberich, Attorney-in-Fact 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DaVita (DVA) report for its CFO?

DaVita reported that CFO Joel Ackerman received two equity grants of common stock as compensation. He acquired 6,585 and 65,997 shares at no cost through performance stock unit awards tied to prior grants, rather than through open-market stock purchases or sales.

Were Joel Ackerman’s DaVita (DVA) transactions open-market buys or sales?

No, the transactions were not open-market buys or sales. They are coded as “A” awards, meaning shares were granted as compensation under performance stock unit programs, with a transaction price of $0.00 per share instead of market trading activity.

How many DaVita (DVA) shares does the CFO hold after these awards?

After the reported equity grants, Joel Ackerman directly holds 221,019 shares of DaVita common stock. This total reflects his position following the two performance-based awards disclosed in the filing, reinforcing his ongoing equity exposure to the company’s future results.

What are the vesting terms of the DaVita (DVA) performance stock units?

The shares relate to performance stock units granted on March 15, 2022 and March 15, 2023. Footnotes state that 100% of these awards will vest on March 15, 2026, tying the CFO’s compensation to longer-term company performance through this future vesting date.

Does the DaVita (DVA) Form 4 indicate any derivative or option exercises?

The Form 4 does not show any derivative or option exercises. All reported transactions are non-derivative common stock awards with code “A” and a zero-dollar price per share, reflecting equity compensation grants rather than exercises of options or other derivative securities.
Davita Inc

NYSE:DVA

View DVA Stock Overview

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

10.23B
33.09M
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER